NXGN has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NXGN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Accounts Receivable are created when a customer has received a product but has not yet paid for that product. NextGen Healthcare's accounts receivables for the quarter that ended in Sep. 2023 was $89.3 Mil.
Accounts receivable can be measured by Days Sales Outstanding. NextGen Healthcare's Days Sales Outstanding for the quarter that ended in Sep. 2023 was 46.18.
In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. NextGen Healthcare's Net-Net Working Capital per share for the quarter that ended in Sep. 2023 was $-2.49.
The historical data trend for NextGen Healthcare's Accounts Receivable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NextGen Healthcare Annual Data | |||||||||||||||||||||
Trend | Mar14 | Mar15 | Mar16 | Mar17 | Mar18 | Mar19 | Mar20 | Mar21 | Mar22 | Mar23 | |||||||||||
Accounts Receivable | Get a 7-Day Free Trial | 87.46 | 80.01 | 77.54 | 76.06 | 88.50 |
NextGen Healthcare Quarterly Data | ||||||||||||||||||||
Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | |
Accounts Receivable | Get a 7-Day Free Trial | 76.95 | 79.42 | 88.50 | 84.12 | 89.28 |
Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.
NextGen Healthcare's Days Sales Outstanding for the quarter that ended in Sep. 2023 is calculated as:
Days Sales Outstanding | |||||
= | Accounts Receivable | / | Revenue | * | Days in Period |
= | 89.277 | / | 176.418 | * | 91 |
= | 46.18 |
2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), NextGen Healthcare's accounts receivable are only considered to be worth 75% of book value:
NextGen Healthcare's Net-Net Working Capital Per Share for the quarter that ended in Sep. 2023 is calculated as:
Net-Net Working Capital Per Share | |||||||
= | (Cash And Cash Equivalents | + | 0.75 * Accounts Receivable | + | 0.5 * Total Inventories | - | Total Liabilities |
- | Preferred Stock | - | Minority Interest) | / | Shares Outstanding (EOP) | ||
= | (200.299 | + | 0.75 * 89.277 | + | 0.5 * 0 | - | 434.475 |
- | 0 | - | 0) | / | 67.097 | ||
= | -2.49 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.
If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.
Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.
Thank you for viewing the detailed overview of NextGen Healthcare's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.
Three Prong Investments, Llc | 10 percent owner | 1695 VIKING RD, LAGUNA BEACH CA 92651 |
David A Metcalfe | officer: Chief Technology Officer | 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305 |
Mitchell Waters | officer: EVP, Commercial Growth | 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305 |
Craig A. Barbarosh | director | 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305 |
David Ahmadzai | officer: Chief Accounting Officer | 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305 |
Donna Cullen Greene | officer: EVP, Human Resources | 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305 |
Srinivas S Velamoor | officer: EVP, Business Development | 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305 |
David William Sides | officer: President and CEO | 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305 |
Arnold James Robert Jr. | officer: Chief Financial Officer | 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305 |
Darnell Dent | director | 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305 |
Pamela Puryear | director | 253 DOLPHIN COVE QUAY, STAMFORD CT 06902 |
Geraldine Mcginty | director | 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305 |
Lonnie Allen Plunk | officer: EVP, Operations | 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305 |
John R Frantz | officer: CEO and President | 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305 |
Lance Rosenzweig | director | 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305 |
From GuruFocus
By PRNewswire • 09-06-2023
By Marketwired • 09-07-2023
By Business Wire • 09-06-2023
By GuruFocus Research • 09-04-2023
By Business Wire • 10-24-2023
By Business Wire • 09-25-2023
By PRNewswire • 08-24-2023
By Marketwired • 10-03-2023
By GuruFocus Research • 10-24-2023
By PRNewswire • 11-04-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.